SCHEMBL4836742

SCHEMBL4836742

O=c1c2cc3c(=O)n(OS(=O)(=O)c4ccc(Cl)cc4)c(=O)c3cc2c(=O)n1OS(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 1/20 0.46
TDP1 Q9NUW8 1/20 0.42
CYP3A4 P08684 2/20 0.41
MAPK1 P28482 1/20 0.41
CMA1 P23946 1/20 0.39
MMP2 P08253 2/20 0.39
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA9 Q16790 3/20 0.38
CA3 P07451 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4829876 0.84 KMT2A (0.50) ALDH1A1HPGDKDM4EMMP2CA12
SCHEMBL12534653 0.83 CA2 (0.41) ALDH1A1HPGDKDM4EMMP2CA12
SCHEMBL4836943 0.83 CA1 (0.38) ALDH1A1HPGDKDM4EMMP2CA12
SCHEMBL4835181 0.83 THRB (0.46) ALDH1A1HPGDKDM4EMMP2CA12
SCHEMBL4835154 0.83 VDR (0.53) ALDH1A1HPGDKDM4ETDP1MAPK1
SCHEMBL4826493 0.82 PARL (0.53) ALDH1A1HPGDKDM4ETDP1CA12
SCHEMBL4834642 0.80 GAA (0.48) TDP1MMP2CA1CA2CA9
SCHEMBL4835108 0.79 PTGS2 (0.43) ALDH1A1MAPK1CA12CA1CA2
SCHEMBL4829946 0.79 VDR (0.55) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL12534680 0.79 CA12 (0.42) ALDH1A1HPGDKDM4ECA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 ALDH1A1 633/4885HPGD 2276/4885KDM4E 2501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.